Navigation Links
Missing Chromosomes Revealed Brain Tumor Therapy Effect – Research Find

Study results have uncovered that missing portions of 2 chromosomes located at 1p and 19q predicted the prognosis of Brain tumor therapy//.

The senior author Walter J. Curran Jr., M.D., professor and chair of radiation oncology at Jefferson Medical College of Thomas Jefferson University in Philadelphia, have found a paradigm shift in managing rare, malignant but treatable brain tumors also known as gliomas.

Reporting last week in the Journal of Clinical Oncology, Dr. Curran and a team of American and Canadian researchers, in conjunction with the Philadelphia-based Radiation Therapy Oncology Group (RTOG), a federally-supported clinical trials organization, found that among 289 patients with either anaplastic oligodendroglioma or anaplastic oligoastrocytoma receiving either a combination of three chemotherapy drugs with radiation or radiation alone, those whose tumors had deletions in chromosome locations 1p and 19q tended to live nearly two and a half times longer than those patients without the missing chromosome portions. The ‘median survival time’ of patients with the deletions was greater than seven years, meaning that one-half lived at least that long. For those with tumors lacking such deletions, one-half lived at least 2.8 years.

‘Leukemias used to be the only cancers where chromosomal deletions were part of the treatment decision-making process,’ says Dr. Curran, who is also clinical director of the Kimmel Cancer Center at Jefferson. ‘Now, testing for such deletions in tumors should become mandatory for at least these types of gliomas.’

In the study, 147 patients received the chemotherapy and radiation, while 142 were given only radiation. These rare, malignant tumors can be effectively treated, though seldom ‘cured’ with surgery and radiation. One controversy, explains Dr. Curran, was whether or not adding chemotherapy early in the treatment will help individuals live longer. Most thought that chemotherapy would be ben eficial.

However, the researchers found little difference in survival after three years between the two groups. While the group who received chemotherapy and radiation lived nearly a year longer without evidence of the cancer growing, nearly two-thirds of those patients experienced significant toxic side effects from the treatment.

Dr. Curran explains that there was some indirect evidence that showed that individuals with these types of tumors who had chromosomal deletions fared better. When the scientists compared the patients who had deletions and those who did not, they found stunning results.

‘While finding unexpectedly that adding chemotherapy didn’t help survival, equally important was the fact that we confirmed in a multicenter trial that the 1p and/or 19q deletion was highly predictive and prognostic of patient outcome, whether the patient received radiation and chemotherapy or radiation alone,’ Dr. Curran says. ‘Whether the patient had one or both deletions, the survival is much better.’

In the same journal issue, a European team showed nearly identical results in a similar trial. Both trials showed such deletions were predictive of survival, Dr. Curran says.

‘These two studies together have shifted the way we think of anaplastic or grade three gliomas,’ he says. ‘Up until now we’ve categorized them based on histologic appearance. We are now categorizing them according to chromosomal deletion status.’

‘That’s actually more predictive than what they look like under the microscope,’ Dr. Curran says. ‘Those who have no chromosomal deletions have outcomes not all that different than the grade four glioblastomas, a much more deadly brain tumor. Those with both deletions are a totally different group of patients.’

‘Testing for chromosomal deletions should be a mandatory part now of the management of these patients based on these two trials.’

‘There has been a shift in clinical trial d esign in the last year,’ he says. ‘Now in patients with gliomas, we are going to apply this to future study design and probably treatment recommendations based on chromosomal deletions. I think more and more centers will begin to use such diagnostic genetics.’
Source: Eurekalert
'"/>




Related medicine news :

1. Gene linked to Missing Eye condition in newborns
2. Missing Protein In Cancer Development
3. Missing teeth associated with blocked arteries
4. Diabetic Girl Reported Missing
5. To Ape or Not To Ape? Bridging Missing Links in Medical Research
6. Missing Medical Store Owners Body Found
7. Needles Given To Drug Addicts Go Missing In Scotland
8. Tourists Face Health Risks by Missing Vaccinations
9. Missing Your Daily Vegetables Takes out Years of Your Life
10. Missing Molecule Has Important Role in a Developmental Brain Abnormality
11. Artificial Teeth Developed to Replace Missing Teeth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... , ... February 08, 2016 , ... ... will be speaking on how healthcare companies can use newly released government data ... health of a population and intervene and capture the value they create to ...
(Date:2/7/2016)... , ... February 07, 2016 , ... Women's Excellence staff, ... Wear Red Day. National Wear Red Day is the first Friday each February ... disease and stroke cause 1 in 3 deaths among women each year – more ...
(Date:2/6/2016)... (PRWEB) , ... February 06, 2016 , ... With the ... easily add warm color grades to their footage. A LUT is a Lookup Table ... color to the corresponding color indicated by the table. By manipulating each pixel, LUT's ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... availability of the company's lighter, sleeker next generation LYNX VR Indoor Trainer with ... , Improvements in design and manufacturing not only reduce the weight of the ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... the addition of micro-needling services in their Napa Valley office. The technique utilizes ... Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Dehaier Medical Systems Ltd. (Nasdaq: ... develops, markets and sells medical devices and wearable ... and international markets, today announced its corporate ... the Company,s resources to develop its mobile health ... focus more on its major businesses. As of ...
(Date:2/5/2016)... France , Germany , ... Israel ). It includes a 10-year epidemiology forecast for the total ... and sex in these markets. GD epidemiology report is written and developed ... transparent and market-driven, providing expert analysis of disease trends in the 7MM. ... Italy , Spain , UK, and ...
(Date:2/4/2016)... -- Worldwide Radiology Oncology surgical robot markets are ... systems provide a way to improve traditional open ... systems pinpoint the delivery of radiation precisely, eliminating ... problem previously, limiting the quantity of radiation that ... far beyond what has been available, promising a ...
Breaking Medicine Technology: